Mergers & Acquisitions - Pharmaceutical, Merck Serono

Filter

Popular Filters

Briefs: Takeda and Lundbeck file vortioxetine NDA; Merck Serono spin-out

03-10-2012

Japan's biggest drugmaker Takeda Pharmaceutical (TYO: 4502) and partner Danish CNS specialist Lundbeck…

AsceneurionBiotechnologyLundbeckMerck KGaAMerck SeronoMergers & AcquisitionsNeurologicalPharmaceuticalRegulationTakeda Pharmaceuticalsvortioxetine

Back to top